Municipal nonprofit organizations (NPO), which most Ukrainian healthcare facilities have become, are trying to develop the healthcare business – which is an absolutely new challenge for them
On January 21, a draft order on amendments to criteria applied to determine medicines which cannot be advertised draft was published. Andrii Gorbatenko analyzed the pros and cons of this document for the pharmaceutical market.
On peculiarities of the law to extend the autonomization clinics (Bill №2428), which will allow medical institutions to enter the medical reform, said counsel at Legal Alliance Company Vitalii Savchuk, especially for the news agency "Interfax-Ukraine".
The draft legislation on reducing pressure on business by market surveillance authorities makes it impossible to duplicate the supervision of one and the same enterprise, think the lawyers of Legal Alliance Company Illya Kostin and Victoria Malyniak.
Lawyer and Law, No. 43, November 28th, 2019 Ivanna Nepyivoda, assistant associate, Legal Alliance Company Recently, Law of Ukraine No. 114-IX "On Amending the
On November 4th, Legal Alliance Company with the support of the Association of Innovative Drug Manufacturers “APRaD” held the discussion club “Discussion Pharma MeetUP on Intellectual Property: Manufacturers of Innovative Drugs vs Generics Manufacturers on Bills No. 2089 and No. 2259.” Details of the discussion in the article from Apteka.ua.
The permission provided for by the law on harmonization of Ukrainian legislation with the EU law in the field of comparative advertising (draft law No. 0953) to openly compare a product with the products of a competitor in advertising can create a problem for consumers in the pharmaceutical market of Ukraine, Andrii Gorbatenko, partner at Legal Alliance Company, believes.
Trends in legal services in the field of pharmaceutical and medical law by partner Dmytro Aleshko specifically for the national rating of Yurydychna Gazeta.
